Drug Trial Radar · NCT07161700
An Open-Label Extension Study to Evaluate the Safety and Tolerability of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 OLE Study)
Last checked: Nov 19, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
360
Planned (sponsor's estimate)
Start
Sep 2, 2025
Primary completion
May 2027
Study completion May 2027
Sponsor
- Lead sponsor
- Seaport TherapeuticsIndustry
- Sponsor type
- Industry
- Collaborators
- Premier Research
- First posted
- Sep 9, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 66 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an open-label, monotherapy, extension study to evaluate the safety and tolerability of SPT-300 (GlyphAllo) in adults with major depressive disorder (MDD), with or without anxious distress.
Conditions
- Major Depressive Disorder (MDD)
- Major Depressive Disorder With Anxious Distress
Interventions
SPT-300Drug
A prodrug of allopregnanolone, a small molecule drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety and tolerability assessments based on Treatment-emergent Adverse Events (TEAEs), Serious Adverse Events (SAEs) and validated clinical scales and proceduresTime frame: Up to Day 49
Locations
46 sites in 7 countries. Site status is shown where the registry gives one.
Seaport Investigator Site
Chino, California
Seaport Investigator Site
Garden Grove, California
Seaport Investigator Site
Glendale, California
Seaport Investigator Site
San Jose, California
Seaport Investigator Site
Cromwell, Connecticut
Seaport Investigator Site
Lauderhill, Florida
Seaport Investigator Site
Palm Bay, Florida
Seaport Investigator Site
West Palm Beach, Florida
Seaport Investigator Site
Atlanta, Georgia
Seaport Investigator Site
Decatur, Georgia
Seaport Investigator Site
Boston, Massachusetts
Seaport Investigator Site
St Louis, Missouri
Seaport Investigator Site
Brooklyn, New York
Seaport Investigator Site
Cedarhurst, New York
Seaport Investigator Site
New York, New York
Seaport Investigator Site
Staten Island, New York
Seaport Investigator Site
Independence, Ohio
Seaport Investigator Site
North Canton, Ohio
Seaport Investigator Site
Dallas, Texas
Seaport Investigator Site
Irving, Texas
Seaport Investigator Site
Richardson, Texas
Seaport Investigator Site
Everett, Washington
Seaport Investigator Site
Lovech, Bulgaria
Seaport Investigator Site
Plovdiv, Bulgaria
Seaport Investigator Site
Sofia, Bulgaria
Seaport Investigator Site
Brno, Czechia
Seaport Investigator Site
Pilsen, Czechia
Seaport Investigator Site
Prague, Czechia
Seaport Investigator Site
Prague, Czechia
Seaport Investigator Site
Prague, Czechia
Seaport Investigator Site
Prague, Czechia
Seaport Investigator Site
Bad Homburg, Germany
Seaport Investigator Site
Chemnitz, Germany
Seaport Investigator Site
Berlin, Brandenburg, Germany
Seaport Investigator Site
Schwerin, Mecklenburg-Vorpommern, Germany
Seaport Investigator Site
Budapest, Hungary
Seaport Investigator Site
Budapest, Hungary
Seaport Investigator Site
Bialystok, Poland
Seaport Investigator Site
Bialystok, Poland
Seaport Investigator Site
Bydgoszcz, Poland
Showing 40 of 46 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.